Skip to main content

Animations

MJFF Publications

5041 - 5050 of 6230 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)
    Journal Name: BMJ Open
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032
    Citation Count: 9
  • Summary Details
    OPEN
    Title: QEEG abnormalities in cognitively unimpaired patients with delirium
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/jnnp-2022-330010
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Investigating structural subdivisions of the anterior cingulate cortex in schizophrenia, with implications for treatment resistance and glutamatergic levels
    Journal Name: Journal of Psychiatry and Neuroscience
    Publisher: CMA Impact Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1503/jpn.210113
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune Disorders
    Journal Name: Current Chinese Chemistry
    Publisher: Bentham Science Publishers Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2174/2666001601666211126091737
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.abm3233
    Citation Count: 165
  • Summary Details
    OPEN
    Title: Unveiling the B cell receptor structure
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.add8065
    Citation Count: 10
  • Summary Details
    OPEN
    Title: A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.abn0044
    Citation Count: 30
  • Summary Details
    OPEN
    Title: GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.abk0637
    Citation Count: 103
  • Summary Details
    OPEN
    Title: Membrane curvature sensing and stabilization by the autophagic LC3 lipidation machinery
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.add1436
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.abm5386
    Citation Count: 131
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.